Humle, Karin
Klanger, Boris http://orcid.org/0009-0003-3507-9724
Kolkhof, Peter
Rosas, Sylvia E.
Rossing, Peter
Wright, Eugene
Jefferson, Nichole
Funding for this research was provided by:
Bayer Corporation
Article History
Received: 23 February 2024
Accepted: 16 April 2024
First Online: 19 July 2024
Declarations
:
: Boris Klanger: Received grants for cooperation with the following companies during the past 5 years: NovoNordisk, Boehringer Ingelheim, Bayer, AstraZeneca, Pfizer, Lilly, Abbott, Sanofi, Amgen, Amarin, Teva, Region Västmanland, Novartis. Eugene Wright: Bayer advisor, consultant, and speaker; Boehringer Ingelheim advisor, consultant, and speaker; GSK consultant and speaker. Sylvia Rosas: Received research funds from and on advisory boards for Bayer and AstraZeneca. Nichole Jefferson: Bayer consultant. Karin Humle: No conflicts of interest. The disclosure information for Peter Rossing and Peter Kolkhof have not changed compared to the original article—for their disclosure information, please see the original article.
: This article is based on previously published studies and does not contain any new studies with human participants or animals performed by any of the authors. Please see the referenced article for ethics relating to the original study.